Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis

Objective: To test whether symptomatic severe intracranial atherosclerotic stenosis was associated with a higher subsequent stroke risk than moderate stenosis after elective angioplasty with a balloon-expandable stent and to explore which factors were associated with the subsequent stroke. Methods: Between September 2001 and June 2005, there were 220 symptomatic intracranial atherosclerotic stenoses in 213 patients undergoing elective stenting at our institute. Of these stenoses, 126 in 121 patients were ≥70% severe stenoses, and 94 in 92 patients were 50% to 69% moderate stenoses. Primary endpoints included lesion-related ischemic stroke, and symptomatic brain or subarachnoid hemorrhage. Results: Ten primary endpoint events occurred in the severe stenosis group (six within 30 days and four in mean follow-up of 26.0 months after 30 days), and seven occurred in the moderate stenosis group (four within 30 days and three in mean follow-up of 27.6 months after 30 days). There was no significant difference in cumulative probability of primary endpoints between the severe (7.2% at 1 year and 8.2% at 2 years) and moderate (5.3% at 1 year and 8.3% at 2 years) stenosis groups. No single factor was found to be associated with primary endpoints in the moderate stenosis group. Multivariable analysis revealed that stent failure was the only predictor of primary endpoints in the severe stenosis group (hazard ratio 5.31, 95% CI 1.35 to 20.91). Conclusion: Symptomatic severe intracranial atherosclerotic stenosis did not present a higher subsequent stroke risk than moderate stenosis after elective angioplasty with a balloon-expandable stent. Patients with severe stenosis may benefit from successful stent placement, and randomized trials are necessary to demonstrate this possible benefit.

[1]  H. Mak,et al.  Perforator stroke after elective stenting of symptomatic intracranial stenosis. , 2007, Neurology.

[2]  S. Kasner,et al.  Predictors of Ischemic Stroke in the Territory of a Symptomatic Intracranial Arterial Stenosis , 2006, Circulation.

[3]  H. Suryapranata,et al.  Homocysteine and its effects on in-stent restenosis. , 2005, Circulation.

[4]  M. Daffertshofer,et al.  Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease , 2005, Neurology.

[5]  Dong Joon Kim,et al.  Stent-assisted angioplasty of symptomatic intracranial vertebrobasilar artery stenosis: feasibility and follow-up results. , 2005, AJNR. American journal of neuroradiology.

[6]  S. Kasner,et al.  Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. , 2005, The New England journal of medicine.

[7]  R. Higashida,et al.  Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis , 2005, Neurology.

[8]  T. Liebig,et al.  Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan) , 2005, Neuroradiology.

[9]  P. Rothwell,et al.  Underestimation of the Early Risk of Recurrent Stroke: Evidence of the Need for a Standard Definition , 2004, Stroke.

[10]  Bin Du,et al.  Stenting of Symptomatic M1 Stenosis of Middle Cerebral Artery: An Initial Experience of 40 Patients , 2004, Stroke.

[11]  Ssylvia Study Investigators.  Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): Study Results , 2004, Stroke.

[12]  F. Zanella,et al.  Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stents--initial experience. , 2004, Radiology.

[13]  L. Lisabeth,et al.  A population-based study of acute stroke and TIA diagnosis , 2004, Neurology.

[14]  James F Sallis,et al.  AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. , 2002, Circulation.

[15]  R. Ceratto,et al.  Angioplasty and stent placement in intracranial atherosclerotic stenoses and dissections. , 2002, AJNR. American journal of neuroradiology.

[16]  G. Albers,et al.  Symptomatic intracranial atherosclerosis , 2000, Neurology.

[17]  H. A. Smith,et al.  A standardized method for measuring intracranial arterial stenosis. , 2000, AJNR. American journal of neuroradiology.

[18]  T. Mima,et al.  Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. , 2000, AJNR. American journal of neuroradiology.

[19]  Takahisa Mori,et al.  Follow-up Study after Intracranial Percutaneous Transluminal Cerebral Balloon Angioplasty , 1998, Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences.

[20]  R. Higashida,et al.  Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial , 1999 .

[21]  Prognosis of patients with symptomatic vertebral or basilar artery stenosis. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. , 1998, Stroke.